To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

November 04, 2019___

Today's Rundown

Featured Story

MD Anderson's Hahn picked as next FDA commissioner

It’s official: President Donald Trump has nominated Stephen Hahn as the next commissioner of the FDA.

Top Stories

Halozyme kills pipeline, cuts 55% of jobs as lead cancer med flops in phase 3

Until today, Halozyme worked under a two-pillar strategy, with licensing dollars from its Enhanze drug delivery technology bankrolling its cancer pipeline. Now, with the failure of its lead program in pancreatic cancer, the company is pulling the plug on drug development to focus solely on Enhanze and cutting 55% of its staff in the process.

FDA tells Aveo no, again, for tivozanib as biotech tries to find yet another path forward

In a "Groundhog Day" scenario, the FDA has once more slapped down Aveo Oncology’s attempt to get its ill-fated cancer drug on the U.S. market.

[Sponsored] Flip the Funnel: Rethinking Patient Recruitment and Enrollment Strategies

No matter how successful advertising campaigns are, all that really matters is how many referrals ultimately participate in the trial. It’s time to flip the funnel and focus on converting recruits into enrollees.

Small Alzheimer's hopeful biotech nabs $15M series B for metabolic drug approach

A small private biotech has raised a modest series B round as it continues to test its idea that the memory-wasting disease can be beaten back by focusing on fat and sugar metabolism in the brain.

U.K. researchers developing 'smell-powered' diagnostic to sniff out diseases

Researchers at the University of Bristol in England are developing a device that mimics the sensitive sense of smell possessed by dogs and other mammals and is capable of sniffing out the faint chemical signatures of chronic diseases.

The 2019 FiercePharma Marketing Awards

Once considered neophytes in the hip and happening ad scene, pharma companies—some of them, at least—are breaking out with smart creative executions, innovative tools and tech-assisted novelties that go beyond standard pharma campaign fare. That’s evident in our first crop of award winners.

Enrollment Showcase

A Credential for the Future of Health Care

Join the future of health care with the flexibility and convenience of an online program.

Resources

[Whitepaper] The importance of early key opinion leader outreach in the biologics and biosimilars marketplace

Acknowledging various stakeholder networks, as well as recognizing variances within the regulatory environment, we believe, is essential for companies looking to uncover the right decision-makers in support of biologics or biosimilars. Learn more.

[Whitepaper] 5 Best Practices for Marketing Medical Devices

Discover solutions to the most common challenges faced by medical device companies.

[Whitepaper] The Impact of Step-Therapy Policies on Patients

Download this complimentary paper that explores the practice of step therapy and its impact on key stakeholders in the US healthcare system.

[Whitepaper] Q2 2019 Biopharma licensing report

18 high-value new licensing deals worth in excess of $500 million took place during the second quarter of 2019 -Get the Q2 2019 Biopharma licensing report for full details and insights.

[Whitepaper] Synthesizing Success: Six Principles For Getting Pharmaceutical Development Right From The Start

Is your API development on track?

[Infographic] Implement the Patient Voice to Build an Effective Engagement App

Get the latest data on how people are using apps to manage their health, and learn how you can leverage it in the development of your next clinical trial app.

[eBook] Customer Experience: Shaping Digital Healthcare

Report: How to design digital services that deliver value and improve outcomes for patients, healthcare professionals and the healthcare systems they serve

[Whitepaper] How to succeed by failing faster

This white paper examines the skyrocketing cost of drug development and provides step-by-step guidance for executing a successful fail fast strategy.

[Article] 8 Compelling Reasons Why Businesses Need To Be In The Cloud Now!

Companies that don’t have a cloud strategy are at a competitive disadvantage. Why? The cloud has a measurable impact on business.

[Whitepaper] Implementing On-Dose Authentication Technologies for Solid Dose Drug Products

Learn about how you better manage product authentication and battle drug counterfeiting with innovative solutions.

[Whitepaper] Innovative Funding Models for Treatment of Cancer and Other High-Cost Chronic Noncommunicable Diseases

A global landscape study of funding trends and innovations.

[Case Study] Clinical Supply Management

Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study.

[Video] Demand Led Services and Clinical Supply Efficiency

Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels.

[eBook] Strategies for Efficient Clinical Supply Management and Forecasting

Download the eBook to explore a proactive approach for clinical supply management.

Events